Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics.

The significance of studying the kinetics of drug partitioning into red blood cells (RBCsb) in animals and humans is not fully appreciated, although the importance of routine determination of rate and extent of partitioning of investigational drugs has been stressed ([Lee et al., 1981b][1]; [

[1]  R. Weinshilboum,et al.  Pharmacogenetics of N‐methylation: Heritability of human erythrocyte histamine N‐methyltransferase activity , 1988, Clinical pharmacology and therapeutics.

[2]  A. Chalmers,et al.  Conversion of azathioprine into mercaptopurine and mercaptoimidazole derivatives in vitro and during immunosuppressive therapy. , 1967, The Australian journal of experimental biology and medical science.

[3]  S. Wallace,et al.  Uptake of acetazolamide by human erythrocytes in vitro. , 1977, Journal of pharmaceutical sciences.

[4]  W. Gratzer.  The red cell membrane and its cytoskeleton. , 1981, The Biochemical journal.

[5]  R. Weinshilboum,et al.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. , 1980, American journal of human genetics.

[6]  J. Stuart,et al.  Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease. , 1989, Clinical science.

[7]  P. Cossum,et al.  Role of the red blood cell in drug metabolism , 1988, Biopharmaceutics & drug disposition.

[8]  William S. Spector.  Handbook of Biological Data , 1956 .

[9]  F. A. Green,et al.  The relative roles of hydrolases of the erythrocyte and other tissues in controlling aspirin survival in vivo. , 1984, Arthritis and rheumatism.

[10]  W. L. Chiou,et al.  Pharmacokinetics of drugs in blood. V: Aberrant blood and plasma concentration profiles of methotrexate during intravenous infusion. , 1986, Biopharmaceutics & drug disposition.

[11]  Y. Amitai,et al.  Tricyclic Antidepressants in Red Cells and Plasma: Correlation with Impaired Intraventricular Conduction in Acute Overdose , 1993, Clinical pharmacology and therapeutics.

[12]  J. Le bras,et al.  Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance , 1985, Antimicrobial Agents and Chemotherapy.

[13]  R. Macleod,et al.  Metabolism of 2',3'-dideoxyinosine (ddI) in human blood. , 1992, British journal of clinical pharmacology.

[14]  L. Dubé,et al.  Comparison of the erythrocyte partitioning method with two classical methods for estimating free drug fraction in plasma. , 1984, Biopharmaceutics & drug disposition.

[15]  R. Weinshilboum,et al.  Human erythrocyte membrane thiol methyltransferase. S-methylation of captopril, N-acetylcysteine, and 7 alpha-thio-spirolactone. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[16]  H. J. Molen,et al.  INTERCONVERSION OF PROGESTERONE AND 20α-DIHYDROPROGESTERONE AND OF ANDROSTENEDIONE AND TESTOSTERONE IN VITRO BY BLOOD AND ERYTHROCYTES , 1968 .

[17]  Y. Bergqvist,et al.  Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. , 1983, Journal of chromatography.

[18]  Wojciech Piekoszewski,et al.  Pharmacokinetics of tacrolimus in liver transplant patients , 1995, Clinical pharmacology and therapeutics.

[19]  E. R. Garrett,et al.  Physicochemical Properties, Solubility, and Protein Binding of Δ9 -Tetrahydrocannabinol , 1974 .

[20]  J. Stuart,et al.  Substituted benzaldehydes (12C79 and 589C80) that stabilize oxyhaemoglobin also protect sickle cells against calcium‐mediated dehydration , 1992, British journal of haematology.

[21]  K. Gambhir,et al.  Insulin degradation by human erythrocyte lysates. , 1981, Clinical chemistry.

[22]  B. Müller-Oerlinghausen,et al.  [Clinical relevance of lithium determination in RBC: results of a catamnestic study (author's transl)]. , 1976, Arzneimittel-Forschung.

[23]  U. Steegmüller,et al.  Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes: different effects of intravenous and oral catecholamine administrations. , 1991, The Journal of pharmacology and experimental therapeutics.

[24]  G R Wilkinson,et al.  Clearance approaches in pharmacology. , 1987, Pharmacological reviews.

[25]  T. Hasegawa,et al.  Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[26]  J. Axelrod,et al.  Methyltransferase enzymes in red blood cells. , 1971, The Journal of pharmacology and experimental therapeutics.

[27]  J. A. Carrillo,et al.  CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine. , 2003, British journal of clinical pharmacology.

[28]  S. Blondheim.  Acetylation by blood cells , 1955 .

[29]  N. D. Kim,et al.  Pharmacokinetics of drugs in blood. VII: Unusual distribution and blood storage effect of vancomycin. , 1992, Biopharmaceutics & drug disposition.

[30]  Arnold L. Smith,et al.  Disposition of drugs in cystic fibrosis. VII. Acetylation of sulfamethoxazole in blood cells: In vitro‐in vivo correlation and characterization of its kinetics of acetylation in lymphocytes , 1994, Clinical pharmacology and therapeutics.

[31]  Determination of oxpentifylline and a metabolite, 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine, by gas--liquid chromatography using a nitrogen-selective detector. , 1980, Journal of chromatography.

[32]  N. Bachur,et al.  Daunorubicin metabolism by human hematological components. , 1972, Cancer research.

[33]  A. Atkinson,et al.  N‐Acetylprocainamide pharmacokinetics in functionally anephric patients before and after perturbation by hemodialysis , 1979, Clinical pharmacology and therapeutics.

[34]  L. Wu,et al.  Interaction of nitroglycerin with human blood components. , 1983, Journal of pharmaceutical sciences.

[35]  E. R. Garrett,et al.  Plasmolysis, red blood cell partitioning, and plasma protein binding of etofibrate, clofibrate, and their degradation products. , 1983, Journal of pharmaceutical sciences.

[36]  K. Schindhelm,et al.  Creatinine transfer between red cells and plasma: a comparison between normal and uremic subjects. , 1978, Nephron.

[37]  H. Rylance,et al.  Erythrocyte and plasma aspirin esterase [letter] , 1981 .

[38]  D. Cutler,et al.  A kinetic study of the role of band 3 anion transport protein in the transport of salicylic acid and other hydroxybenzoic acids across the human erythrocyte membrane. , 1992, Journal of pharmaceutical sciences.

[39]  I. Trautschold,et al.  Insulin binding and degradation by human erythrocytes and erythrocyte membranes , 1982 .

[40]  C. Goresky,et al.  Red Cell Carriage of Label: ITS LIMITING EFFECT ON THE EXCHANGE OF MATERIALS IN THE LIVER , 1975, Circulation research.

[41]  R. Nagel,et al.  On the mechanism for the red-cell accumulation of mefloquine, an antimalarial drug. , 1984, Biochimica et biophysica acta.

[42]  J. Powell,et al.  A Single‐dose pharmacokinetic study of the antisickling agent cetiedil , 1986, Clinical pharmacology and therapeutics.

[43]  W. Henry,et al.  Insulin binding and degradation by human erythrocytes at physiological temperature. , 1981, Endocrinology.

[44]  A. Atkinson,et al.  Simultaneous analysis of inulin and 15N2‐urea kinetics in humans , 1993, Clinical pharmacology and therapeutics.

[45]  E. Delpire,et al.  Erythrocyte K-Cl cotransport: properties and regulation. , 1992, The American journal of physiology.

[46]  H. Belle.  Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine? , 1993 .

[47]  R. Weinshilboum,et al.  Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia , 1990, The Lancet.

[48]  A. Carruthers,et al.  Effects of lipid environment on membrane transport: the human erythrocyte sugar transport protein/lipid bilayer system. , 1988, Annual review of physiology.

[49]  J. Kelly,et al.  Digoxin “receptors” in neonates: An explanation of less sensitivity to digoxin than in adults , 1980, Clinical pharmacology and therapeutics.

[50]  R. Weinshilboum,et al.  Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies. , 1982, The Journal of pharmacology and experimental therapeutics.

[51]  D. Morgan,et al.  Effect of erythrocyte binding on elimination of harmol by the isolated perfused rat liver. , 1996, Journal of pharmaceutical sciences.

[52]  G. Kootstra,et al.  FK 506: monitoring in plasma or in whole blood? , 1991, Transplantation proceedings.

[53]  F. Barton,et al.  Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. , 1995, Controlled clinical trials.

[54]  A. Berliner,et al.  The binding of phenothiazines to oxyhemoglobin A and S. , 1973, Research communications in chemical pathology and pharmacology.

[55]  J. Pappenheimer,et al.  Renal extraction of PAH and of diodrast-I131 as a function of arterial red cell concentration. , 1956, The American journal of physiology.

[56]  W. L. Chiou,et al.  Pharmacokinetics of drugs in blood. I. Unusual distribution of gentamicin. , 1981, Biopharmaceutics & drug disposition.

[57]  M. Laakso,et al.  NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects , 1994, Diabetes.

[58]  L. Chesley.  Documenta geigy: Scientific tables , 1964 .

[59]  M H Bickel,et al.  Prediction of drug distribution in distribution dialysis and in vivo from binding to tissues and blood. , 1993, Journal of pharmaceutical sciences.

[60]  A. K. Solomon,et al.  THE AQUEOUS PORE IN THE RED CELL MEMBRANE: BAND 3 AS A CHANNEL FOR ANIONS, CATIONS, NONELECTROLYTES, AND WATER * , 1983, Annals of the New York Academy of Sciences.

[61]  J. Hoffman,et al.  Determination of membrane potentials in human and Amphiuma red blood cells by means of a fluorescent probe , 1974, The Journal of physiology.

[62]  M. Broggini,et al.  Adriamycin distribution in plasma and blood cells of cancer patients with altered hematocrit. , 1981, European journal of cancer & clinical oncology.

[63]  R. Garay,et al.  Erythrocyte ion transport as indicator of sensitivity to antihypertensive drugs. , 1994, The American journal of the medical sciences.

[64]  I. M. Klotz,et al.  Acylation of hemoglobin by aspirin-like diacyl esters. , 1984, Journal of pharmaceutical sciences.

[65]  A. Breckenridge,et al.  The disposition of amodiaquine in man after oral administration. , 1987, British journal of clinical pharmacology.

[66]  P. Seeman,et al.  The membrane concentration of a local anesthetic (chlorpromazine). , 1969, Biochimica et biophysica acta.

[67]  P. Dunham,et al.  Asymmetry of Na-K-Cl cotransport in human erythrocytes. , 1988, The American journal of physiology.

[68]  W. L. Chiou,et al.  Erythrocytes as a total barrier for renal excretion of hydrochlorothiazide: slow influx and efflux across erythrocyte membranes. , 1992, Journal of pharmaceutical sciences.

[69]  C Y Quon,et al.  Biochemical properties of blood esmolol esterase. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[70]  C. Migeon,et al.  IN VITRO INTERCONVERSION OF 16-C-ESTRONE AND 16-C-ESTRADIOL-17beta BY ERYTHROCYTES FROM NORMAL SUBJECTS AND FROM SUBJECTS WITH A DEFICIENCY OF RED CELL GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACTIVITY. , 1962, The Journal of clinical investigation.

[71]  J. Stamler,et al.  S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control , 1996, Nature.

[72]  Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development , 1992 .

[73]  D. Jollow,et al.  Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. , 1988, The Journal of pharmacology and experimental therapeutics.

[74]  B. Weatherley,et al.  The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjects. , 1993, British journal of clinical pharmacology.

[75]  H. Rylance,et al.  Erythrocyte and plasma aspirin esterase. , 1981, British journal of clinical pharmacology.

[76]  R. Gorczynski.  Basic Pharmacology of Esmolol , 1986 .

[77]  P. Armstrong,et al.  Rapid disappearance of nitroglycerin following incubation with human blood. , 1980, Canadian journal of physiology and pharmacology.

[78]  C. Kunin,et al.  Uptake of antibiotics by human erythrocytes. , 1976, The Journal of infectious diseases.

[79]  K. Eckert.  The metabolism of aminophenols in erythrocytes. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[80]  J. Delaunay,et al.  Genetic disorders of the red cell membrane. , 1995, Critical reviews in oncology/hematology.

[81]  E. R. Garrett,et al.  Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite. , 1974, Journal of pharmaceutical sciences.

[82]  F. Jamali,et al.  Hematologic Disposition of Hydroxychloroquine Enantiomers , 1994, Journal of clinical pharmacology.

[83]  R. Keenan,et al.  Blood distribution of rapamycin. , 1993, Transplantation.

[84]  Schatzmann Hj.  Cardiac glycosides as inhibitors of active potassium and sodium transport by erythrocyte membrane , 1953 .

[85]  P. Noonan.  Formation of mono- and dinitrate metabolites of nitroglycerin following incubation with human blood , 1982 .

[86]  K. Sweeney,et al.  Effect of salicylate on serum protein binding and red blood cell uptake of acetazolamide in vitro. , 1988, Journal of pharmaceutical sciences.

[87]  W. Bayne,et al.  Time course and disposition of methazolamide in human plasma and red blood cells. , 1981, Journal of pharmaceutical sciences.

[88]  C. Goresky,et al.  A linear method for determining liver sinusoidal and extravascular volumes. , 1963, The American journal of physiology.

[89]  J. Pappenheimer,et al.  Role of red blood corpuscles in regulation of renal blood flow and glomerular filtration rate. , 1956, The American journal of physiology.

[90]  S. Riegelman,et al.  Acetylsalicylic acid hydrolysis in human blood and plasma. I. Methodology and in vitro studies. , 1967, Journal of pharmaceutical sciences.

[91]  P. Hinderling,et al.  Protein binding and erythrocyte partitioning of the antirheumatic proquazone. , 1981, Journal of pharmaceutical sciences.

[92]  Ö. Ericsson,et al.  Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples. , 1985, Therapeutic drug monitoring.

[93]  T. Maren,et al.  Carbonic anhydrase: chemistry, physiology, and inhibition. , 1967, Physiological reviews.

[94]  E. Mulder,et al.  Isolation and characterization of 17 -hydroxy steroid dehydrogenase from human erythrocytes. , 1972, The Biochemical journal.

[95]  M L Terrin,et al.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. , 1995, The New England journal of medicine.

[96]  J. Wieth,et al.  Chloride and Hydrogen Ion Distribution between Human Red Cells and Plasma , 1966 .

[97]  A. Danon,et al.  Uptake and metabolism of catecholamines by the human red blood cell , 1972, Clinical pharmacology and therapeutics.

[98]  P. Stemmer,et al.  Influence of red blood cells, serum albumin, and serum lipoproteins on the clearance of benzo[alpha]pyrene by isolated livers of 3-methylcholanthrene-treated rats. , 1984, Biochemical pharmacology.

[99]  F. Bowyer.  The Kinetics of the Penetration of Nonelectrolytes into the Mammalian Erythrocyte , 1957 .

[100]  J. Johnson,et al.  Passage of organic bases into human red cells. , 1961, The Journal of pharmacology and experimental therapeutics.

[101]  P. Hinderling.  Kinetics of partitioning and binding of digoxin and its analogues in the subcompartments of blood. , 1984, Journal of pharmaceutical sciences.

[102]  A. K. Solomon,et al.  Permeability of Red Cell Membranes to Small Hydrophilic and Lipophilic Solutes , 1971, The Journal of general physiology.

[103]  J. Davis,et al.  Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophrenia. , 1980, Archives of general psychiatry.

[104]  J. Pappenheimer,et al.  Hematocrit ratio of blood within mammalian kidney and its significance for renal hemodynamics. , 1956, The American journal of physiology.

[105]  K. Ogawa,et al.  Erythrocyte digoxin concentration , 1982, Clinical pharmacology and therapeutics.

[106]  N. Cutler,et al.  Acetylcholinesterase inhibition by zifrosilone: Pharmacokinetics and pharmacodynamics , 1995, Clinical pharmacology and therapeutics.

[107]  S. Blondheim,et al.  Acetylation of p-aminobenzoic acid by human blood. , 1981, Biochemical pharmacology.

[108]  J. Jeffrey,et al.  RAPID PASSAGE OF ORGANIC ANIONS INTO HUMAN RED CELLS. , 1964, The American journal of physiology.

[109]  E. R. Garrett,et al.  Pharmacokinetics of papaverine hydrochloride and the biopharmaceutics of its oral dosage forms. , 1978, International journal of clinical pharmacology and biopharmacy.

[110]  N. Beeching,et al.  Metabolism of didanosine (ddI) by erythrocytes: pharmacokinetic implications. , 1993, British Journal of Clinical Pharmacology.

[111]  D. Drayer,et al.  In vitro acetylation of drugs by human blood cells. , 1974, Drug metabolism and disposition: the biological fate of chemicals.

[112]  F. Markwardt,et al.  [Enzymatic reduction of estrone]. , 1954, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie.

[113]  H. Jun,et al.  Distribution of tetracycline in red blood cells. , 1980, Journal of pharmaceutical sciences.

[114]  I. M. Klotz,et al.  Modification of hemoglobin with analogs of aspirin. , 1980, The Journal of biological chemistry.

[115]  F. Follath,et al.  Temperature dependency of apparent cyclosporin A concentrations in plasma. , 1983, Clinical chemistry.

[116]  D. Fremstad,et al.  Plasma protein binding of drugs as influenced by blood collection methods. , 2009, Acta pharmacologica et toxicologica.

[117]  P. Deetjen,et al.  [Hemodynamics of kidney medullary substance. Part I. Capillary passage time, blood volume, circulation, tissue hematocrit and oxygen consumption of kidney medullary substance in situ]. , 1960, Pflugers Archiv fur die gesamte Physiologie des Menschen und der Tiere.

[118]  A. Rostami-Hodjegan,et al.  The accumulation of mercaptopurine metabolites in age fractionated red blood cells. , 1995, British journal of clinical pharmacology.

[119]  K. Hellström,et al.  Binding‐site interaction of chlorthalidone and acetazolamide, two drugs transported by red blood cells , 1975, Clinical pharmacology and therapeutics.

[120]  R. Calvo,et al.  Effects of disease and acetazolamide on procaine hydrolysis by red blood cell enzymes , 1980, Clinical pharmacology and therapeutics.

[121]  J. Hadfield,et al.  The binding of vinblastine by platelets in the rat. , 1970, Cancer research.

[122]  T. Zimmerman,et al.  Metabolism of 5-amino-1-beta-D-ribofuranosylimidazole-4-carboxamide and related five-membered heterocycles to 5'-triphosphates in human blood and L5178Y cells. , 1978, Biochemical pharmacology.

[123]  W. Jusko,et al.  Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin‐dependent diabetes , 1995, Clinical pharmacology and therapeutics.

[124]  H. Ginsburg,et al.  The transport of chloroquine across human erythrocyte membranes is mediated by a simple symmetric carrier. , 1982, Biochimica et biophysica acta.

[125]  S. Tang,et al.  Haloperidol reduction can be assayed in human red blood cells. , 1989, Canadian journal of physiology and pharmacology.

[126]  O. Y. Hu,et al.  Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing , 1995, Clinical pharmacology and therapeutics.

[127]  W. L. Chiou,et al.  Pharmacokinetics in blood IV: unusual distribution, storage effect and metabolism of methotrexate. , 1984, International journal of clinical pharmacology, therapy, and toxicology.

[128]  F. Di Carlo,et al.  Bunolol metabolism by human and rat red blood cells and extrahepatic tissues. , 1974, The Journal of pharmacology and experimental therapeutics.

[129]  J. Connor,et al.  The metabolism of ribavirin in erythrocytes and nucleated cells. , 1990, The International journal of biochemistry.

[130]  S. Urien,et al.  Binding of indapamide to serum proteins and erythrocytes. , 1988, Biochemical pharmacology.

[131]  J. Meyer,et al.  The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum. , 1995, British journal of clinical pharmacology.

[132]  J. Maddocks,et al.  Assay of 6‐thioguanine nucleotide, a major metabolite of azathioprine, 6‐mercaptopurine and 6‐thioguanine, in human red blood cells , 1983, The Journal of pharmacy and pharmacology.

[133]  H Connor,et al.  Metformin kinetics in healthy subjects and in patients with diabetes mellitus. , 1981, British journal of clinical pharmacology.

[134]  S. Takahara,et al.  In‐vivo Distribution and Erythrocyte Binding Characteristics of Cyclosporin in Renal Transplant Patients , 1996, The Journal of pharmacy and pharmacology.

[135]  M. Pirmohamed,et al.  Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes. , 1991, British journal of clinical pharmacology.

[136]  M. Danhof,et al.  The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine. , 1996, British journal of clinical pharmacology.

[137]  M. E. Veronese,et al.  Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method. , 1988, British journal of clinical pharmacology.

[138]  R. Weinshilboum,et al.  S-Methylation of D- and L-penicillamine by human erythrocyte membrane thiol methyltransferase. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[139]  M. Bickel.  Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components , 1975, The Journal of pharmacy and pharmacology.

[140]  M. Noel.  KINETIC STUDY OF NORMAL AND SUSTAINED RELEASE DOSAGE FORMS OF METFORMIN IN NORMAL SUBJECTS , 1980 .

[141]  J. Rotrosen,et al.  Rapid in vitro sulfoxidation of chlorpromazine by human blood: inhibition by an endogenous plasma protein factor. , 1979, Life sciences.

[142]  F. Sjöqvist,et al.  Distribution of chloroquine in human blood fractions. , 1988, Methods and findings in experimental and clinical pharmacology.

[143]  J. Thliveris,et al.  Distribution of cyclosporin G (NVa2 cyclosporin) in blood and plasma. , 1993, Clinical chemistry.

[144]  S. Urien,et al.  Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes. , 1992, Biochemical pharmacology.

[145]  J. Ambrus,et al.  Dose‐response effects of pentoxifylline on erythrocyte filterability: Clinical and animal model studies , 1990, Clinical pharmacology and therapeutics.

[146]  P. Armstrong,et al.  Sex-related difference in the metabolism of isosorbide dinitrate following incubation in human blood. , 1983, Biochemical pharmacology.

[147]  R. Weinshilboum,et al.  Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. , 1992, Pharmacogenetics.

[148]  W. L. Chiou,et al.  Pharmacokinetics of drugs in blood II. Unusual distribution and storage effect of furosemide. , 1981, Research communications in chemical pathology and pharmacology.

[149]  Bioavailability of flufenamic acid in hard and soft gelatin capsules. , 1976, Journal of pharmaceutical sciences.

[150]  B. Fichtl,et al.  Binding of drugs to tissues. , 1983, Drug metabolism reviews.

[151]  L. Holder,et al.  Diffusion of sulfonamides in aqueous buffers and into red cells. , 1965, Molecular Pharmacology.

[152]  R. Weinshilboum,et al.  Thiol S‐methylation in uremia: Erythrocyte enzyme activities and plasma inhibitors , 1980, Clinical pharmacology and therapeutics.

[153]  R. Mcpherson,et al.  EVIDENCE OF A CYCLOSPORINE‐BINDING PROTEIN IN HUMAN ERYTHROCYTES , 1986, Transplantation.

[154]  W. L. Chiou,et al.  Pharmacokinetics of drugs in blood III: Metabolism of procainamide and storage effect of blood samples. , 1983, Journal of pharmaceutical sciences.

[155]  J. Owen,et al.  Diacetylmorphine (heroin) hydrolases in human blood. , 1983, Canadian journal of physiology and pharmacology.

[156]  W. Boguth,et al.  Distribution of sulfonamides and sulfonamide potentiators between red blood cells, proteins and aqueous phases of the blood of different species. , 1976, Chemotherapy.

[157]  W. Jusko,et al.  Monitoring FK 506 concentrations in plasma and whole blood. , 1991, Transplantation proceedings.

[158]  P. Bonate,et al.  Uptake and biodisposition of 2‐ylcyanamide‐1,3,4‐thiadiazole (LY217896) by red blood cells , 1995, Biopharmaceutics & drug disposition.

[159]  I. M. Klotz,et al.  Acetylation of sickle cell hemoglobin by aspirin. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[160]  M. Hooks.  Tacrolimus, a New Immunosuppressant—A Review of the Literature , 1994, The Annals of pharmacotherapy.

[161]  D. Cutler,et al.  Uptake of chloroquine by human erythrocytes. , 1990, Biochemical pharmacology.

[162]  B. Deuticke.  Properties and structural basis of simple diffusion pathways in the erythrocyte membrane. , 1977, Reviews of physiology, biochemistry and pharmacology.

[163]  G. Wilkinson,et al.  Erythrocyte uptake and plasma binding of di phenyl hydantoin , 1974, Clinical pharmacology and therapeutics.

[164]  H. Fung,et al.  Kinetic mechanisms for the concentration dependency of in vitro degradation of nitroglycerin and glyceryl dinitrates in human blood: metabolite inhibition or cosubstrate depletion? , 1989, Journal of pharmaceutical sciences.

[165]  W. Jusko,et al.  An improved pharmacodynamic model for formation of methemoglobin by antimalarial drugs. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[166]  R. Day,et al.  A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers. , 1988, British journal of clinical pharmacology.